» Articles » PMID: 32249997

Facial Nerve Paralysis in 64 Equids: Clinical Variables, Diagnosis, and Outcome

Overview
Date 2020 Apr 7
PMID 32249997
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Facial nerve paralysis (FNP) in equids is not well described in the veterinary literature.

Objective: To investigate the causes of FNP and associations among clinical variables, diagnosis, and outcome.

Animals: Sixty-four equids presenting with FNP between July 2000 and April 2019. Cases of postanesthetic FNP were excluded.

Methods: Medical records were retrospectively reviewed. Variables were evaluated for associations with outcomes (diagnosis and case outcome) using logistic regression.

Results: The most common cause of FNP was trauma (n = 20). Additional diagnoses included central nervous system (CNS) disease (n = 16), idiopathic (n = 12, 4 of which had adequate diagnostic investigation and were considered "true" idiopathic, and 8 of which were considered "not investigated" idiopathic), temporohyoid osteoarthropathy (n = 10), otitis media-interna (n = 3), lymphoma (n = 1), iatrogenic as a consequence of infiltration of local anesthetic (n = 1), and clostridial myositis (n = 1). Follow-up was available for 55 (86%) cases. Twenty-nine (53%) equids had full resolution of FNP, 14 (25%) were euthanized, 6 (11%) partially improved, and 6 (11%) were unchanged or worse.

Conclusions And Clinical Importance: If FNP is the consequence of CNS disease, successful treatment of the primary disease likely leads to resolution of FNP. Most cases of FNP in equids are traumatic in origin. True idiopathic cases are uncommon.

Citing Articles

Therapeutic potential of mesenchymal stem cells transplantation on traumatic facial nerve paralysis in two horses.

de Oliveira Ferreira L, Maia L, de Andrade D, da Costa Kamura B, de Carvalho M, Amorim R Vet Res Commun. 2025; 49(2):118.

PMID: 39998709 DOI: 10.1007/s11259-025-10692-1.


Equine conjunctival haemangiosarcoma: Clinical presentation, management, and outcome of seven cases in the United Kingdom.

Kashani-Carver A, OHalloran C, Scurrell E, Featherstone H, de Freitas F, Lowe R Open Vet J. 2023; 13(10):1366-1378.

PMID: 38027397 PMC: 10658016. DOI: 10.5455/OVJ.2023.v13.i10.17.


In Vitro Transdifferentiation Potential of Equine Mesenchymal Stem Cells into Schwann-Like Cells.

de Oliveira Ferreira L, da Costa Kamura B, Oliveira J, Chimenes N, de Carvalho M, Alves Dos Santos L Stem Cells Dev. 2023; 32(13-14):422-432.

PMID: 37071193 PMC: 10401561. DOI: 10.1089/scd.2022.0274.


Facial nerve paralysis in 64 equids: Clinical variables, diagnosis, and outcome.

Boorman S, Scherrer N, Stefanovski D, Johnson A J Vet Intern Med. 2020; 34(3):1308-1320.

PMID: 32249997 PMC: 7255662. DOI: 10.1111/jvim.15767.

References
1.
Johnstone L, Engiles J, Aceto H, Buechner-Maxwell V, Divers T, Gardner R . Retrospective Evaluation of Horses Diagnosed with Neuroborreliosis on Postmortem Examination: 16 Cases (2004-2015). J Vet Intern Med. 2016; 30(4):1305-12. PMC: 5094551. DOI: 10.1111/jvim.14369. View

2.
Wagner B, Freer H, Rollins A, Erb H, Lu Z, Grohn Y . Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods. Vet Immunol Immunopathol. 2011; 144(3-4):374-81. DOI: 10.1016/j.vetimm.2011.08.005. View

3.
Motta L, Altay U, Skerritt G . Bell's palsy with concomitant idiopathic cranial nerve polyneuropathy in seven dogs. J Small Anim Pract. 2011; 52(7):397. DOI: 10.1111/j.1748-5827.2011.01086.x. View

4.
Peitersen E . Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002; (549):4-30. View

5.
James K, Smith W, Conrad P, Packham A, Guerrero L, Ng M . Seroprevalences of anti-Sarcocystis neurona and anti-Neospora hughesi antibodies among healthy equids in the United States. J Am Vet Med Assoc. 2017; 250(11):1291-1301. DOI: 10.2460/javma.250.11.1291. View